Krystal Biotech, Inc.
KRYSBiotechnology
$324.55+0.97%As of Oct 29vs prior close
- Market cap
- $9.6B
- P/E (TTM)
- 39.2×
- P/E (FY1)
- 42.8×
- From 52W high
- −14.17%
- EPS (LTM)
- $7.97
- Revenue (LTM)
- $440.5M
- Net margin
- 54.82%
- Dividend yield
- 0.00%
Nomior Score
83
Vanguard CompounderTop 1% of the scored universe
Growth67
Quality80
Value51
Momentum92
Resilience59
Growth
$440.5Mrevenue, LTM
FY21 $0LTM $440.5M
Connections
Revenue to profitQ2 FY26
46% of revenue became net profit, up 6 pts on a year.
Who owns it
2funds, 1 tracked portfolio